Log In
Print this Print this

PRAME (GSK2302025A)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionRecombinant PRAME (preferentially expressed antigen of melanoma) protein plus AS15 adjuvant
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityBiologic

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today